T. Rowe Price Health Care ETF
TMED
3 hedge funds and large institutions have $2.3M invested in T. Rowe Price Health Care ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
865% more capital invested
Capital invested by funds: $238K → $2.3M (+$2.06M)
200% more funds holding
Funds holding: 1 → 3 (+2)
14.82% more ownership
Funds ownership: 2.4% → 17.21% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$1.19M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$508K |
| 3 |
EFS
Essex Financial Services
Essex,
Connecticut
|
+$229K |
Top Sellers
TMED Hedge Fund Activity: Q3 2025 in Review
3 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in T. Rowe Price Health Care ETF (TMED) for Q3 2025, worth a combined $2.3M — up 865% from $238K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TMED positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Flow Traders U.S., opening a new position worth an estimated $1.19M.
- 3 institutional investors held T. Rowe Price Health Care ETF (TMED) as of Q3 2025, up from 1 in Q2 2025.
- Funds reported $2.3M of T. Rowe Price Health Care ETF stock for Q3 2025, up 865% quarter-over-quarter.
- 2 funds opened new T. Rowe Price Health Care ETF positions in Q3 2025 and 0 closed out, a net change of +2 holders.
- The largest T. Rowe Price Health Care ETF buyer in Q3 2025 was Flow Traders U.S., an estimated $1.19M added.
Based on aggregated 13F filings for Q3 2025.